| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K04800985 |
| PharmacoGx | BRD-K04800985 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RP11-343C2.9 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.03 |
| mRNA | C14orf159 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.03 |
| mRNA | PSTPIP2 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.03 |
| mRNA | CLEC14A | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |
| mRNA | BSDC1 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | VAC14 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.03 |
| mRNA | WDR3 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.03 |
| mRNA | SH3D21 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |
| mRNA | LYZ | CTRPv2 | pan-cancer | AAC | 0.085 | 0.03 |
| mRNA | EDIL3 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.03 |
